Study of Tixagevimab/Cilgavimab and Regdanvimab Efficacy for Treatment of COVID-19
Clinical trial NCT05982704 · UNKNOWN
Trial details
- NCT number
- NCT05982704
- Sponsor
- City Clinical Hospital No.52 of Moscow Healthcare Department
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-18
- Primary completion
- 2022-09-19
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.